Scott Juda - 17 Nov 2021 Form 4 Insider Report for Inmune Bio, Inc. (INMB)

Role
Director
Signature
/s/ Scott Juda
Issuer symbol
INMB
Transactions as of
17 Nov 2021
Net transactions value
+$33,875
Form type
4
Filing time
17 Nov 2021, 17:10:36 UTC
Previous filing
24 Jun 2021
Next filing
23 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INMB Common Stock Purchase $33,875 +2,500 +9.1% $13.55 30,000 17 Nov 2021 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person's shares are held by Fossick Capital LP ("Fossick"), a limited partnership. The Reporting Person holds all voting and dispositive control over the Issuer's shares of common stock held by Fossick.